SYF Stock - Synchrony Financial
Unlock GoAI Insights for SYF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $20.76B | $17.34B | $13.20B | $11.22B | $12.83B |
| Gross Profit | $9.39B | $7.66B | $8.30B | $9.47B | $5.85B |
| Gross Margin | 45.2% | 44.2% | 62.9% | 84.3% | 45.6% |
| Operating Income | $4.55B | $2.90B | $3.96B | $5.50B | $1.80B |
| Net Income | $3.50B | $2.24B | $3.02B | $4.22B | $1.39B |
| Net Margin | 16.9% | 12.9% | 22.9% | 37.6% | 10.8% |
| EPS | $8.64 | $5.21 | $6.19 | $7.40 | $2.28 |
Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products, such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual cards, co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms. In addition, it provides debt cancellation products to its credit card customers through online, mobile, and direct mail; healthcare payments and financing solutions under the CareCredit, Pets Best, and Walgreens brands; payments and financing solutions in the apparel, specialty retail, outdoor, music, and luxury industries; and point-of-sale consumer financing for audiology products and dental services. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. It serves digital, health and wellness, retail, home, auto, powersports, jewelry, pets, and other industries. Synchrony Financial was founded in 1932 and is headquartered in Stamford, Connecticut.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 8th 2025 | Wolfe Research | Resumed | Outperform | $92 |
| December 5th 2025 | Robert W. Baird | Downgrade | Neutral | $82 |
| October 10th 2025 | HSBC Securities | Upgrade | Buy | $81 |
| October 7th 2025 | JP Morgan | Downgrade | Neutral | $75 |
| August 1st 2025 | Rothschild & Co Redburn | Initiation | Neutral | $72 |
| July 14th 2025 | BTIG Research | Upgrade | Buy | $100 |
| April 7th 2025 | Morgan Stanley | Downgrade | Equal Weight | $44 |
| January 28th 2025 | Compass Point | Downgrade | Neutral | $70 |
| January 6th 2025 | Barclays | Upgrade | Overweight | $79← $59 |
| December 19th 2024 | Morgan Stanley | Upgrade | Overweight | $82← $40 |
| December 9th 2024 | JP Morgan | Upgrade | Overweight | $72← $59 |
| December 3rd 2024 | Wells Fargo | Upgrade | Overweight | $85← $60 |
| September 16th 2024 | BTIG Research | Downgrade | Neutral | - |
| August 9th 2024 | BofA Securities | Upgrade | Buy | $54 |
| July 16th 2024 | Compass Point | Initiation | Buy | $56 |
Earnings History & Surprises
SYFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 20, 2026 | — | — | — | — |
Q1 2026 | Jan 27, 2026 | $1.98 | — | — | — |
Q4 2025 | Oct 15, 2025 | $2.22 | $2.86 | +28.8% | ✓ BEAT |
Q3 2025 | Jul 22, 2025 | $1.82 | $2.50 | +37.4% | ✓ BEAT |
Q2 2025 | Apr 22, 2025 | $1.67 | $1.89 | +13.2% | ✓ BEAT |
Q1 2025 | Jan 28, 2025 | $1.93 | $1.91 | -1.0% | ✗ MISS |
Q4 2024 | Oct 16, 2024 | $1.79 | $1.94 | +8.4% | ✓ BEAT |
Q3 2024 | Jul 17, 2024 | $1.35 | $1.55 | +14.8% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $1.34 | $1.18 | -11.9% | ✗ MISS |
Q1 2024 | Jan 23, 2024 | $0.93 | $1.03 | +10.8% | ✓ BEAT |
Q4 2023 | Oct 24, 2023 | $1.43 | $1.48 | +3.5% | ✓ BEAT |
Q3 2023 | Jul 18, 2023 | $1.24 | $1.32 | +6.5% | ✓ BEAT |
Q2 2023 | Apr 19, 2023 | $1.46 | $1.35 | -7.5% | ✗ MISS |
Q1 2023 | Jan 23, 2023 | $1.11 | $1.26 | +13.5% | ✓ BEAT |
Q4 2022 | Oct 25, 2022 | $1.38 | $1.47 | +6.5% | ✓ BEAT |
Q3 2022 | Jul 18, 2022 | $1.43 | $1.60 | +11.9% | ✓ BEAT |
Q2 2022 | Apr 18, 2022 | $1.54 | $1.77 | +14.9% | ✓ BEAT |
Q1 2022 | Jan 28, 2022 | $1.48 | $1.48 | 0.0% | = MET |
Q4 2021 | Oct 19, 2021 | $1.51 | $2.00 | +32.5% | ✓ BEAT |
Q3 2021 | Jul 20, 2021 | $1.43 | $2.12 | +48.3% | ✓ BEAT |
Latest News
Wells Fargo Maintains Overweight on Synchrony Financial, Raises Price Target to $95
📈 PositiveWolfe Research Assumes Synchrony Financial at Outperform, Announces Price Target of $92
📈 PositiveBaird Downgrades Synchrony Financial to Neutral, Maintains Price Target to $82
➖ NeutralShares of banks and financial services stocks are trading higher after Fed Governor Waller called for a December rate cut.
📈 PositiveTruist Securities Maintains Hold on Synchrony Financial, Lowers Price Target to $78
➖ NeutralWells Fargo Maintains Overweight on Synchrony Financial, Raises Price Target to $85
📈 PositiveBarclays Maintains Overweight on Synchrony Financial, Raises Price Target to $86
📈 PositiveBTIG Reiterates Buy on Synchrony Financial, Maintains $100 Price Target
📈 PositiveSynchrony Financial Narrows FY2025 Sales Guidance from $15.000B-$15.300B to $15.000B-$15.100B vs $17.825B Est
📉 NegativeSynchrony Financial GAAP EPS of $2.86 beats by $0.64, revenue of $3.82B beats by $20M
📈 PositiveSynchrony Finl Q3 EPS $2.86 Beats $2.20 Estimate, Sales $4.720B Beat $4.692B Estimate
📈 PositiveShares of broader financial services stocks are trading higher amid an overall market rebound on hopes of easing US-China trade tensions.
📈 PositiveHSBC Upgrades Synchrony Financial to Buy, Raises Price Target to $81
📈 PositiveUBS Maintains Neutral on Synchrony Financial, Raises Price Target to $79
➖ NeutralJP Morgan Downgrades Synchrony Financial to Neutral, Lowers Price Target to $75
📉 NegativeBarclays Maintains Overweight on Synchrony Financial, Raises Price Target to $83
📈 PositiveKeefe, Bruyette & Woods Maintains Outperform on Synchrony Financial, Raises Price Target to $86
📈 PositiveEvercore ISI Group Maintains Outperform on Synchrony Financial, Raises Price Target to $84
📈 PositiveMorgan Stanley Maintains Equal-Weight on Synchrony Financial, Raises Price Target to $82
📈 PositiveJMP Securities Maintains Market Outperform on Synchrony Financial, Raises Price Target to $88
📈 PositiveFrequently Asked Questions about SYF
What is SYF's current stock price?
What is the analyst price target for SYF?
What sector is Synchrony Financial in?
What is SYF's market cap?
Does SYF pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to SYF for comparison